Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Insights, Size and Growth Forecast To 2030

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends Analysis By Product & service, By Application, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Apr 2022 Base Year: 2021 Report ID: BIOT2217
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 180
Category : Biotechnology
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview:

According to SPER Market Research, the Digital PCR (dPCR) and Real-time PCR (qPCR) Market estimated to reach USD 11.39 billion by 2030 with a CAGR of 8.8%. The key fuels for the market escalation are; advanced PCR technologies, growing investments, increasing genetic as well as targeted infectious disease, raising the exploit of biomarkers profiling in the disease diagnosis, and the booming Human Genome project.
Impact of COVID-19 on the Digital PCR (dPCR) and Real-time PCR (qPCR) Market 
The COVID-19 outbreak has mainly impacted to the healthcare industry; diagnostic industry is one of them. There is a positive impact in the PCR industries. Digital PCR (dPCR) and Real-time PCR (qPCR) has the importance in the diagnostic and drug discovery. The focus of the companies is to produce digital PCR kits for the diagnosis of the infection. 

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Product & Service, By Application, By End-User, By Region
 Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa
 Companies CoveredAbbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton, Dikinson and Compan, bioMérieux SA, Bioneer, Bio-Rad Laboratories Inc.Dan, aher Corporation, ELITech Group, Enzo Life Sciences, Inc., Eppendorf, F. Hoffmann-La Roche, Ltd., Fluidigm Corporation, Merck KGaA, Meridian Bioscience, Promega Corporation, QIAGEN N.V., Quidel Corporation, Thermo Fisher Scientific, Takara Bio

Driver: growing occurrence of target infectious diseases and genetic disorders
Rising incidence of target infectious diseases and genetic disorders, technological advancements in PCR technologies, increasing investments, funds, and grants, increasing use of biomarker profiling for disease diagnostics, successful completion of the Human Genome Project; are the key drives of the escalation of the market.

Restraint: High device costs coupled with dPCR
Technical limitations of qPCR and dPCR techniques, costly device coupled with dPCR; can resist the escalation of the market.

Opportunity: rising market penetration in emerging countries
Growing market penetration in emerging countries, shift from plant-derived to genome-based drug discovery; offers enormous opportunities to the players in the market.

Challenges:
Adoption and implementation of MIQE guidelines, is the challenge to the market expansion.



Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:

By Product & Service: Based on the Product and Service, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmended as; qPCR Products & Services (qPCR Reagents and Consumables, qPCR Instruments, qPCR Software and Services), dPCR Products & Services (dPCR Instruments, dPCR Reagents and Consumables, dPCR Software and Services).

By Application: Based on the Application, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmended as; qPCR Applications (Clinical Applications, Forensic Applications, Research Applications), dPCR Applications (Clinical Applications, Research Applications, Forensic Applications).

By End-User: Based on the End-User, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmended as; qPCR End User (Clinical Research Organizations, Forensic Laboratories, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes), qPCR End User (Clinical Research Organizations, Forensic Laboratories, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes).
By Region: North America, dominates the principal share of this market; and this is because of accessibility to research & development funding, growing acceptance of innovative and novel genomic analysis, escalating use of PCR techniques in the clinical diagnostics, forensics, and commercialization of qPCR/dPCR products.

1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges 
4.2. COVID-19 Impacts of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1 Strengths 
5.1.2 Weaknesses 
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis 
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape 
5.2.4 Technological landscape 
5.2.5 Environmental landscape 
5.2.6 Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1 Bargaining power of suppliers 
5.3.2 Bargaining power of Buyers 
5.3.3 Threat of Substitute 
5.3.4 Threat of new entrant 
5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Product & Service, 2019-2030 (USD Million)
6.1.  qPCR Products & Services
6.1.1. qPCR Reagents and Consumables
6.1.2. qPCR Instruments
6.1.3. qPCR Software and Services
6.2.  dPCR Products & Services
6.2.1. dPCR Instruments
6.2.2. dPCR Reagents and Consumables
6.2.3. dPCR Software and Services

7. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Application, 2019-2030 (USD Million)
7.1. qPCR Applications
7.1.1.  Clinical Applications
7.1.2.  Forensic Applications
7.1.3.  Research Applications
7.2. dPCR Applications
7.2.1.  Clinical Applications
7.2.2.  Research Applications
7.2.3.  Forensic Applications

8. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By End-User, 2019-2030 (USD Million)
8.1. dPCR End User
8.1.1. Clinical Research Organizations
8.1.2. Forensic Laboratories
8.1.3. Hospitals and Diagnostic Centers
8.1.4. Pharmaceutical and Biotechnology Companies
8.1.5. Research Laboratories and Academic Institutes
8.2. qPCR End User
8.2.1. Clinical Research Organizations
8.2.2. Forensic Laboratories
8.2.3. Hospitals and Diagnostic Centers
8.2.4. Pharmaceutical and Biotechnology Companies
8.2.5. Research Laboratories and Academic Institutes

9. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Region, 2019-2030 (USD Million)
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia-Pacific
9.4. South America
9.5. Middle East & Africa
9.5.1. Kingdom of Saudi Arabia 
9.5.2. United Arab Emirates
9.5.3. Rest of Middle East & Africa

10. Company Profiles
10.1. Abbott Laboratories 
10.1.1. Company details 
10.1.2. Financial outlook
10.1.3. Product summary 
10.1.4. Recent developments
10.2. Agilent Technologies 
10.2.1. Company details 
10.2.2. Financial outlook
10.2.3. Product summary 
10.2.4. Recent developments
10.3. Analytik Jena AG
10.3.1. Company details 
10.3.2. Financial outlook
10.3.3. Product summary 
10.3.4. Recent developments
10.4. Becton Dikinson and Company 
10.4.1. Company details 
10.4.2. Financial outlook
10.4.3. Product summary 
10.4.4. Recent developments
10.5. bioMérieux SA 
10.5.1. Company details 
10.5.2. Financial outlook
10.5.3. Product summary 
10.5.4. Recent developments
10.6. Bioneer 
10.6.1. Company details 
10.6.2. Financial outlook
10.6.3. Product summary 
10.6.4. Recent developments
10.7. Bio-Rad Laboratories Inc. 
10.7.1. Company details 
10.7.2. Financial outlook
10.7.3. Product summary 
10.7.4. Recent developments
10.8. Danaher Corporation 
10.8.1. Company details 
10.8.2. Financial outlook
10.8.3. Product summary 
10.8.4. Recent developments
10.9. ELITech Group
10.9.1. Company details 
10.9.2. Financial outlook
10.9.3. Product summary 
10.9.4. Recent developments
10.10. Enzo Life Sciences, Inc.
10.10.1. Company details 
10.10.2. Financial outlook
10.10.3. Product summary 
10.10.4. Recent developments
10.11. Eppendorf
10.11.1. Company details 
10.11.2. Financial outlook
10.11.3. Product summary 
10.11.4. Recent developments
10.12. F. Hoffmann-La Roche, Ltd. 
10.12.1. Company details 
10.12.2. Financial outlook
10.12.3. Product summary 
10.12.4. Recent developments
10.13. Fluidigm Corporation
10.13.1. Company details 
10.13.2. Financial outlook
10.13.3. Product summary 
10.13.4. Recent developments
10.14. Merck KGaA
10.14.1. Company details 
10.14.2. Financial outlook
10.14.3. Product summary 
10.14.4. Recent developments
10.15. Meridian Bioscience 
10.15.1. Company details 
10.15.2. Financial outlook
10.15.3. Product summary 
10.15.4. Recent developments
10.16. Promega Corporation 
10.16.1. Company details 
10.16.2. Financial outlook
10.16.3. Product summary 
10.16.4. Recent developments
10.17. QIAGEN N.V. 
10.17.1. Company details 
10.17.2. Financial outlook
10.17.3. Product summary 
10.17.4. Recent developments
10.18. Quidel Corporation 
10.18.1. Company details 
10.18.2. Financial outlook
10.18.3. Product summary 
10.18.4. Recent developments
10.19. Takara Bio
10.19.1. Company details 
10.19.2. Financial outlook
10.19.3. Product summary 
10.19.4. Recent developments
10.20. Thermo Fisher Scientific
10.20.1. Company details 
10.20.2. Financial outlook
10.20.3. Product summary 
10.20.4. Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us